RNS Number:7328M
Hikma Pharmaceuticals Plc
27 November 2006


Hikma Pharmaceuticals PLC
27 November 2006

NOTIFICATION OF TRANSACTION OF DIRECTOR/PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY AND CONNECTED PERSONS

This form is intended for use by an issuer to make a RIS notification required 
by DR 3.1.4R(1).


(1)  An issuer making a notification in respect of a transaction relating to the 
     shares or debentures of the issuer should complete boxes 1 to 16, 23 and 
     24.

(2)  An issuer making a notification in respect of a derivative relating to the 
     shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 
     24.

(3)  An issuer making a notification in respect of options granted to a director
     /person discharging managerial responsibilities should complete boxes 1 to 
     3 and 17 to 24.
     
(4)  An issuer making a notification in respect of a financial instrument 
     relating to the shares of the issuer (other than a debenture) should 
     complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.



Please complete all relevant boxes should in block capital letters.


1. Name of the issuer

HIKMA PHARMACEUTICALS PLC

....................................

2. State whether the notification relates to (i) a transaction notified in
accordance with DR 3.1.4R(1)(a); or

(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as
extended by section 328) of the Companies Act 1985; or

(iii) both (i) and (ii)

(i)

....................................

3. Name of person discharging managerial responsibilities/director

MR GABRIEL KALISSE

....................................

4. State whether notification relates to a person connected with a person
discharging managerial responsibilities/director named in 3 and identify the
connected person

MS MONA RAFIQ SHUHAIBAR (SPOUSE)

....................................

5. Indicate whether the notification is in respect of a holding of the person
referred to in 3 or 4 above or in respect  of a non-beneficial interest

4 ABOVE

....................................

6. Description of shares (including class), debentures or derivatives or
financial instruments relating to shares

ORDINARY SHARES OF 10 PENCE EACH

....................................

7. Name of registered shareholders(s) and, if more than one, the number of
shares held by each of them

MS MONA RAFIQ SHUHAIBAR

....................................

8 State the nature of the transaction

SALE OF SHARES

....................................

9. Number of shares, debentures or financial instruments relating to shares
acquired

N/A

....................................

10. Percentage of issued class acquired (treasury shares of that class should
not be taken into account when  calculating percentage)

N/A

....................................

11. Number of shares, debentures or financial instruments relating to shares 
disposed

88,000

....................................

12. Percentage of issued class disposed (treasury shares of that class should
not be taken into account when  calculating percentage)

0.052%

....................................

13. Price per share or value of transaction

395.76 PENCE PER SHARE

....................................

14. Date and place of transaction

24 NOVEMBER 2006, LONDON

....................................

15. Total holding following notification and total percentage holding following
notification (any treasury shares  should not be taken into account when
calculating percentage)

100,000 (0.0596%)

....................................

16. Date issuer informed of transaction

27 NOVEMBER 2006

....................................

If a person discharging managerial responsibilities has been granted options by 
the issuer complete the following boxes


17 Date of grant

....................................

18. Period during which or date on which it can be exercised

....................................

19. Total amount paid (if any) for grant of the option

....................................

20. Description of shares or debentures involved (class and number)

....................................

21. Exercise price (if fixed at time of grant) or indication that price is to be
fixed at the time of exercise

....................................

22. Total number of shares or debentures over which options held following
notification

....................................

23. Any additional information

N/A

....................................

24. Name of contact and telephone number for queries

HENRY KNOWLES, COMPANY SECRETARY, 020 7399 2760

....................................

Name and signature of duly authorised officer of issuer responsible for making 
notification

HENRY KNOWLES, COMPANY SECRETARY, 020 7399 2760

....................................

Date of notification

27 NOVEMBER 2006

....................................

END




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
RDSKGMZMLNKGVZG
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Hikma Pharmaceuticals Charts.
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Hikma Pharmaceuticals Charts.